Clofarabine

This is a powerful medicine used to treat certain types of leukemia, especially in children. It works by stopping the growth of cancer cells. It's given in a hospital setting.

Brand names:Clolar, Evoltra
Medication

What people taking Clofarabine report

Every report comes from a Lived member, sent anonymously.

Have you tried Clofarabine for Acute Lymphoblastic Leukemia (ALL)?

NameHow it went

About Clofarabine

What It's For

Clofarabine is an intravenous chemotherapy medicine for acute lymphoblastic leukemia (ALL), a cancer of the white blood cells. In the US it is approved for children and young adults aged 1 to 21 whose ALL has come back (relapsed) or has not responded (refractory) after at least two earlier treatment regimens. That makes it a later-line option, used when standard treatments have stopped working. The aim is to bring the leukemia back into remission, which for some people opens the way to a stem cell transplant. The original US brand, Clolar, has been discontinued, and the medicine is now supplied in the US as generic clofarabine injection. In Europe it is sold as Evoltra.

How It Works

Leukemia cells divide rapidly, and each division requires copying the cell's DNA. Clofarabine is a nucleoside analog: it closely resembles one of the natural building blocks of DNA. Once inside a cell, it is converted to an active form that blocks the enzymes that make and copy DNA, and it gets built into new DNA strands where it halts further copying and repair. It also damages the cell's mitochondria in a way that triggers the cell's self-destruct program. These effects are not limited to cancer cells. Healthy cells that divide quickly, especially in the bone marrow and the lining of the gut, are also affected, which explains why low blood counts, infections and digestive side effects are so common.

Dosage & Administration

Clofarabine is given only in a hospital or specialized infusion center. It runs into a vein over about 2 hours once a day for 5 days in a row, which makes up one cycle. The dose is calculated from the person's body surface area, worked out from height and weight before each cycle. Cycles are repeated every 2 to 6 weeks, once blood counts and organ function have recovered enough. During the 5 infusion days, the team usually gives extra IV fluids and medicines to protect the kidneys from the breakdown products of dying leukemia cells (tumor lysis syndrome), along with anti-nausea medicine. They check blood pressure, heart function, kidney and liver tests closely. The dose may be lowered or a cycle delayed if kidney function is reduced or side effects are severe.

Side Effects

Most people have side effects. Vomiting, nausea and diarrhea are very common, as are fever, chills, headache, itching, rash, tiredness, poor appetite, belly pain and a fast heartbeat. Nosebleeds and small red or purple spots on the skin (petechiae) are also common because platelet counts drop. The most important risk is very low blood counts, which can be severe and last weeks. In studies, more than half of patients developed fever while their infection-fighting white cells were low, and most had at least one infection, some of them fatal. Fever, chills or other signs of infection need a call to the cancer team right away, day or night. Easy bruising, unusual bleeding, marked weakness or shortness of breath should also be reported, since serious bleeding can occur when platelets are low. Less often, clofarabine causes a body-wide inflammatory reaction in which fluid leaks out of blood vessels (capillary leak syndrome), shown by fast breathing, a racing heart, low blood pressure or fluid around the lungs. The team monitors closely for it during treatment and stops the medicine if it develops. Yellowing of the skin or eyes should be reported promptly, as should a severe rash that blisters or peels, and heavy or persistent diarrhea or belly pain, which can signal serious bowel inflammation.

Interactions & Warnings

Clofarabine can injure the liver and kidneys, sometimes severely. For this reason the care team will try to avoid other medicines that strain these organs during the 5 infusion days. Before and during each cycle, check with the team before taking any new prescription, over-the-counter pain reliever or herbal product. People who have already had a stem cell transplant have a higher risk of veno-occlusive disease, a dangerous blockage of small veins in the liver, especially when clofarabine is combined with other chemotherapy. Clofarabine can harm a developing baby. Both male and female patients who could conceive a child should use effective contraception during treatment, and breastfeeding should be avoided. The cancer team can advise how long to continue contraception afterward.

What to Expect

Treatment is intensive and usually involves time in the hospital or daily visits during each 5-day course, followed by frequent blood tests while counts are low. Most people who respond do so after one or two cycles. It is important to have realistic expectations. In the main study of children and young adults with heavily pretreated ALL, about 1 in 5 reached remission, and remissions often lasted a few months. Because remissions with clofarabine alone tend to be short, some people who reach remission go on to a stem cell transplant. If the leukemia does not respond, the team will discuss other options, which may include a clinical trial.

Questions to Ask Your Doctor

  1. 1.Why is clofarabine the best option now, compared with other treatments or a clinical trial?
  2. 2.What are the chances of remission, and if it works, is a stem cell transplant the plan?
  3. 3.Will treatment happen in the hospital, and who should we call if a fever starts at night?
  4. 4.How will you protect the kidneys and liver, and which medicines or supplements should we avoid?
  5. 5.How many cycles do you expect, and how will we know whether it is working?

Last reviewed • Oct 2026

Educational content, not medical advice.